Improving early detection and management of oral cancer
Optimizing Oral Cancer Screening and Precision Management of Potentially Malignant Oral Lesions
This study is looking at new ways to spot oral cancers early, especially a type called oral squamous cell carcinoma, so that patients can get the right treatment sooner and avoid more invasive procedures like biopsies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10894120 on NIH RePORTER |
What this research studies
This research focuses on enhancing the early detection of oral cancers, particularly oral squamous cell carcinoma (OSCC), which is often diagnosed at late stages. By utilizing advanced diagnostic tools, including an AI-assisted cytopathology tool, the project aims to improve the accuracy of identifying potentially malignant oral lesions. This approach seeks to reduce the need for invasive procedures like biopsies and to provide timely treatment options for patients. The goal is to enable less disfiguring and more cost-effective therapies through early intervention.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals over 21 years old who are at risk for oral cancers or have potentially malignant oral lesions.
Not a fit: Patients with confirmed oral cancer or those who do not have any oral lesions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate detection of oral cancers, significantly improving patient outcomes.
How similar studies have performed: Previous research has shown promise in using AI and advanced diagnostic tools for cancer detection, indicating potential success for this innovative approach.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Kang, Stella — New York University School of Medicine
- Study coordinator: Kang, Stella
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.